Dissolve DCB, a novel triglyceride-based paclitaxel-coated balloon, is non-inferior to the next-generation SeQuent Please for in-segment late lumen loss (LLL) in patients with drug-eluting stent (DES) in-stent restenosis (ISR), new trial data report.